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Familial cardiomyopathies are a leading cause of sudden death in young people, and 
as of now, there is no known cure. While mouse models and patient heart tissue have 
been extraordinarily useful in the study of the disease pathogenesis, the physiological 
differences between mouse and human cardiomyocytes can introduce many 
inconsistencies in disease presentation. Additionally, tissue from patients with the disease 
is difficult to obtain and it has undergone many compensations that make it difficult 
to understand the early stages of the disease pathogenesis. To develop a new model of 
the disease, we are using human stem cell derived cardiomyocytes bearing mutations 
that cause familial hypertrophic cardiomyopathies. We have introduced these mutations 
using CRISPR. Wild type stem cells were differentiated into cardiomyocytes. Immuno-
staining helped assess sarcomeric organization and traction force microscopy provided 
a tool to measure the force produced by single cardiomyocytes. We are now beginning to 
apply the same tools to study a hypertrophic cardiomyopathy disease causing mutation 
in troponin T, R92Q.
